Chromosome mapping inPseudomonas aeruginosa-Reference-Cited by-同舟云学术

Chromosome mapping inPseudomonas aeruginosa

Published:1972-06 Issue:3 Volume:19 Page:251-260
ISSN:0016-6723
Container-title:Genetical Research
language:en
Short-container-title:Genet. Res.

Author:

Pemberton J. M.,Holloway B. W.

Abstract

SUMMARYA more extensive linkage map ofPseudomonas aeruginosastrain PAO has been compiled from data obtained by both, conjugation and transduction procedures. All the markers examined are located on one linkage group and the available evidence suggests that the sex factor FP2 promotes transfer of the chromosome in a polarized manner from only one site on this linkage group.

Publisher

Hindawi Limited

Subject

Genetics,General Medicine

Reference23 articles.

1. Recombination in Escherichia coli III. Mapping by the gradient of transmission

2. LYSOGENY IN PSEUDOMONAS AERUGINOSA

3. An analysis of histidine requiring mutants in Pseudomonas aeruginosa;Mee;Genetics,1967

4. Acetylornithmase of Escherichia coli: partial purification and some properties;Vogel;Journal of Biological Chemistry,1956

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pseudomonas aeruginosa Strains from Both Clinical and Environmental Origins Readily Adopt a Stable Small-Colony-Variant Phenotype Resulting from Single Mutations in c-di-GMP Pathways;Journal of Bacteriology;2022-10-18

2. Pseudomonas aeruginosa strains from both clinical and environmental origins readily adopt a stable small colony variant (SCV) phenotype resulting from single mutations in c-di-GMP pathways;2022-06-04

3. The ability of Pseudomonas aeruginosa to adopt a Small Colony Variant (SCV) phenotype is conserved, and not restricted to clinical isolates;2021-02-08

4. Carbapenems as inhibitors of OXA-13, a novel, integron-encoded β-lactamase in Pseudomonas aeruginosa;Microbiology;1998-04-01

5. Aminoglycoside 6′- N -Acetyltransferase Variants of the Ib Type with Altered Substrate Profile in Clinical Isolates of Enterobacter cloacae and Citrobacter freundii;Antimicrobial Agents and Chemotherapy;1998-02